NRx Pharmaceuticals, Inc.
NRXP
$2.69
$0.051.89%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/25/2025
-
TipRanks Financial Blog
8/25/2025
-
The Fly
8/21/2025
-
TipRanks Financial Blog
8/21/2025
-
The Fly
8/21/2025
-
GuruFocus
8/21/2025
-
GuruFocus
8/20/2025
-
SeekingAlpha.com: All News
8/20/2025
-
Seeking Alpha: Transcripts
8/19/2025
-
GuruFocus
8/19/2025
-
GuruFocus
8/19/2025
-
SeekingAlpha.com: All News
8/18/2025
-
TipRanks Financial Blog
8/18/2025
-
GuruFocus
8/18/2025
-
GuruFocus
8/18/2025
-
TipRanks Financial Blog
8/18/2025
-
TipRanks Financial Blog
8/18/2025
-
The Fly
8/18/2025
-
The Fly
8/18/2025
-
GuruFocus
8/18/2025
-
Globe Newswire
8/13/2025
-
GuruFocus
8/13/2025
-
GuruFocus
8/13/2025
-
PR Newswire
8/13/2025
-
Benzinga
8/12/2025
-
Stocktwits News Feed
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, August 18, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
484 254 6134
Address
1201 Orange Street
Wilmington, DE 19801
Wilmington, DE 19801
Country
Year Founded
Business Description
Sector
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression...
more